vimarsana.com

Cindy Hsin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glucose-lowering drugs reduce risk for obesity-related cancers

CHICAGO — Glucagon-like peptide-1 receptor agonists lowered the risk for obesity-related cancers compared with bariatric surgery among individuals with a BMI of at least 35, according to data presented at ASCO Annual Meeting. Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) conferred a greater risk reduction in all-cause mortality, despite inferior weight loss results

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.